These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 18584586

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients.
    Abdelhamid S, Müller-Lobeck H, Pahl S, Remberger K, Bönhof JA, Walb D, Röckel A.
    Arch Intern Med; 1996 Jun 10; 156(11):1190-5. PubMed ID: 8639013
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Therapy-resistant hypertension--the endocrinological view].
    Beuschlein F, Reincke M.
    MMW Fortschr Med; 2007 Mar 01; 149(9):29-32. PubMed ID: 17612246
    [Abstract] [Full Text] [Related]

  • 28. Malignant aldosterone-producing adrenal tumour: reoccurrence with glucocorticoid excess without hyperaldosteronism.
    Abma EM, Kluin PM, Dullaart RP.
    Neth J Med; 2008 Jun 01; 66(6):252-5. PubMed ID: 18689909
    [Abstract] [Full Text] [Related]

  • 29. Conn's syndrome due to adrenocortical adenoma--a rare but rewarding cause of curable hypertension.
    Quarmby CJ, Burch VC, Dent DM, Opie LH.
    S Afr Med J; 1995 Dec 01; 85(12 Pt 2):1353-6. PubMed ID: 8600610
    [Abstract] [Full Text] [Related]

  • 30. Clinical characteristics of primary hyperaldosteronism due to adrenal microadenoma.
    Karashima S, Takeda Y, Cheng Y, Yoneda T, Demura M, Kometani M, Ohe M, Mori S, Yagi K, Yamagishi M.
    Steroids; 2011 Nov 01; 76(12):1363-6. PubMed ID: 21801737
    [Abstract] [Full Text] [Related]

  • 31. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C.
    Am J Hypertens; 1995 Sep 01; 8(9):884-93. PubMed ID: 8541003
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Primary Hyperaldosteronism Due to Adrenocortical Adenoma: a Case Report.
    Pemayun TGD, Naibaho R, Wiyati MW, Santosa A, Amarwati S.
    Acta Med Indones; 2017 Jul 01; 49(3):249-254. PubMed ID: 29093236
    [Abstract] [Full Text] [Related]

  • 35. [Primary hyperaldosteronism--12 clinical cases].
    Telles EC, Machado FS, da Silva EP, Lutucuta S, Almeida G, Coucelo J, Vagueiro C.
    Rev Port Cardiol; 1999 Sep 01; 18(9):801-12. PubMed ID: 10536470
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Modification of the protocol for selective adrenal venous sampling results in both a significant increase in the accuracy and necessity of the procedure in the management of patients with primary hyperaldosteronism.
    Harvey A, Pasieka JL, Kline G, So B.
    Surgery; 2012 Oct 01; 152(4):643-9; discussion 649-51. PubMed ID: 22929402
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.